Use of Pattern Analysis to Identify True Drug Response: A Replication

Archives of General Psychiatry

Volumn 44, Issue 3, 1987, Pages 259-264

  Quitkin, Frederic M ^a,b   Rabkin, Judith D ^a,b   Markowitz, Jefferey M ^a,b   Stewart, Jonathan W ^a,b   Mcgrath, Patrick J ^a,b   Harrison, Wilma ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Department of Psychiatry College of Physicians and Surgeons Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIDEPRESSANT AGENT; DESIPRAMINE; IMIPRAMINE; MIANSERIN; PHENELZINE; PLACEBO;

AFFECTIVE NEUROSIS; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG COMPARISON; DRUG EFFECT; DRUG EFFICACY; HUMAN; METHODOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; THERAPY;

ACTUARIAL ANALYSIS; CLINICAL TRIALS; DEPRESSIVE DISORDER; HUMANS; IMIPRAMINE; PATIENT DROPOUTS; PATTERN RECOGNITION, AUTOMATED; PHENELZINE; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; RANDOM ALLOCATION; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0023149820     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1987.01800150071009     Document Type: Article

References (13)

1. Klerman GL, Cole JO: Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol Rev 1965;17:101-104.
2. Davis JM, Klerman GL, Schildkraut JJ: Drugs used in the treatment of depression, in Effrom DH (ed): Psychopharmacology: A Review of Progress 1957-1967. Washington, DC, American College of Neuropsychopharmacology and the Psychopharmacology Research Branch, National Institute of Mental Health, Public Health Service, US Dept of Health, Education, and Welfare, 1968, pp 719-747.
3. Klein DF, Davis JM: Diagnosis and Drug Treatment of Psychiatric Disorders. Baltimore, Williams & Wilkins, 1969.
4. Kessler KA: Tricyclic antidepressants: Mode of action and clinical use, in Lipton MA, Dimascio A, Killam KE (eds): Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978, pp 1289-1302.
5. Klerman GL: Long-term treatment of affective disorders, in Lipton MA, Dimascio A, Killam KE (eds): Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978, pp 1303-1311.
6. Baldessarini RJ: Drugs and treatment of psychiatric disorders, in Gilman AG, Goodman LS, Gilman A (eds): The Pharmacologic Basis of Therapeutics, ed 6. New York, MacMillan Publishing Co, 1980, pp 391-447.
7. Klein DF, Gittleman R, Quitkin F, Rifkin R: Diagnosis and Drug Treatment of Psychiatric Disorders, ed 2. Baltimore, Williams & Wilkins, 1980.
8. Quitkin FM, Rabkin J, Ross D, Stewart JW: Identification of true drug response to antidepressants. Arch Gen Psychiatry 1984;41:782-786.
9. Flemenbaum A, Escobar JI, Schiele BC: Clomipramine: A doubleblind comparison of intravenous versus oral administration in depressed patients. Psychopharmacologica 1973;33:111-116.
10. Abrams R: Multiple ECT: What have we learned? in Fink M, Kety S, McGaugh J, Williams TA (eds): Psychobiology of Convulsive Therapy. Washington, DC, WH Winston & Sons, 1974.
11. Buchsmaum MS, Reider R: Biologic heterogeneity and psychiatric research. Arch Gen Psychiatry 1979;36:1163-1169.
12. Mann JJ: Loss of antidepressant effect with long-term monoamine oxidase inhibitor: Treatment without loss of monoamine oxidase inhibition. J Clin Psychopharmacol 1983;3:363-366.
13. Robinson DS: Pharmacological aspects of prevention of recurrences of mood disorders, in Mood Disorders: Pharmacological Prevention of Recurrences. Consensus Development Conference, April 24-26, 1984. Washington, DC, Clinical Center, National Institutes of Health, pp 33-37.